ISRCTN55334531已完成不适用
Optimum platelet inhibition after coronary artery bypass surgery: a prospective, randomised trial comparing platelet aggregation using low- and medium-dose aspirin and clopidogrel
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 个研究点目标入组 108 人开始时间: 2003年9月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 108
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •72 Patients and 36 controls will be recruited from patients proceeding to coronary artery bypass surgery.
排除标准
- •Does not match inclusion criteria
研究者
相似试验
已完成
不适用
Coronary intervention and optimal AntiPlatelet Therapy-Optical coherence tomography studyJPRN-UMIN000013719Osaka General Medical Center200
进行中（未招募）
1 期
DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial InjuryStable coronary artery disease.MedDRA version: 17.0 Level: PT Classification code 10011078 Term: Coronary artery disease System Organ Class: 10007541 - Cardiac disordersEUCTR2014-000952-26-GBniversity of Edinburgh202
进行中（未招募）
1 期
Treatment with medications that prevent the formation of blood clots, in the primary prevention of heart disease in patients with a stable lung condition called Chronic Obstructive Pulmonary Disease (COPD).EUCTR2014-005475-86-GBThe Newcastle upon Tyne Hospitals NHS Foundation Trust120
进行中（未招募）
不适用
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGESubjects who present with an acute coronary syndrome.MedDRA version: 12.0Level: LLTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.0Level: PTClassification code 10051592Term: Acute coronary syndromeMedDRA version: 12.0Level: LLTClassification code 10006894Term: CABGEUCTR2008-001135-35-CZThe Medicines Company220
进行中（未招募）
不适用
Maintenance of platelet inhiBition with cangreloR after dIscontinuation ofthienopyriDines in patients undergoing surGEry: The BRIDGE trial - BRIDGEEUCTR2008-001135-35-GBThe Medicines Company220